LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -12.27%10.36B | 255.28%5.21B | -98.37%46M | -89.37%265M | -3.74%4.84B | 36.47%11.81B | -30.11%1.47B | -13.92%2.83B | 100.32%2.49B | 147.68%5.03B |
Net income from continuing operations | -29.67%3.78B | 38.75%1.54B | -43.06%825M | 7.88%1.63B | -116.23%-212M | -20.79%5.37B | -9.41%1.11B | -47.84%1.45B | -3.82%1.51B | 7.76%1.31B |
Operating gains losses | 72.04%2.71B | -113.10%-198M | 2,780.00%1.01B | 284.62%48M | 3,212.50%1.86B | 234.21%1.58B | 2,156.72%1.51B | 102.12%35M | -129.21%-26M | -82.61%56M |
Deferred tax | 94.27%-95M | 118.88%256M | -58.33%-152M | 2.02%-97M | 5.56%-102M | -251.48%-1.66B | -679.31%-1.36B | 28.36%-96M | -230.00%-99M | 19.40%-108M |
Change in working capital | -65.83%1.19B | 629.77%2.97B | -440.03%-2.29B | -683.24%-2.05B | -15.44%2.56B | 497.26%3.49B | -325.30%-561M | -57.09%672M | 130.77%352M | 3,577.01%3.03B |
-Change in receivables | -256.68%-7.85B | 647.44%3.1B | -414.33%-3.09B | -736.46%-5.25B | -543.49%-2.62B | -19.41%-2.2B | -137.24%-567M | -194.64%-600M | 65.87%-628M | -2.01%-407M |
-Change in loss and loss adjustment expense reserves | -201.20%-591M | 58.02%-377M | 63.67%-89M | -438.66%-657M | -65.30%532M | 273.81%584M | -20.70%-898M | -158.89%-245M | 229.33%194M | 979.58%1.53B |
-Change in payables and accrued expense | 79.55%9.9B | -9.82%1.74B | -74.68%355M | 343.10%4.24B | 190.40%3.57B | 57.73%5.51B | 10.19%1.92B | 113.07%1.4B | -11.40%956M | 11,072.73%1.23B |
-Change in other current assets | -18.89%-1.03B | -31.03%-1.61B | 8.25%105M | -79.21%-543M | 79.33%1.02B | 17.73%-868M | -61.79%-1.23B | 140.93%97M | -7.83%-303M | 154.95%566M |
-Change in other working capital | 67.17%774M | -42.79%119M | 2,288.89%430M | 23.31%164M | -41.35%61M | 42.46%463M | -15.10%208M | -81.05%18M | 177.08%133M | 265.08%104M |
Cash from discontinued operating activities | ||||||||||
Operating cash flow | -12.27%10.36B | 255.28%5.21B | -98.37%46M | -89.37%265M | -3.74%4.84B | 36.47%11.81B | -30.11%1.47B | -13.92%2.83B | 100.32%2.49B | 147.68%5.03B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 59.37%-2.1B | 56.59%-191M | 41.96%-776M | -54.59%-640M | 83.41%-495M | -267.01%-5.17B | 28.57%-440M | -130.07%-1.34B | -1.47%-414M | -820.68%-2.98B |
Net investment purchase and sale | 91.46%-248M | -97.06%2M | 63.24%-150M | -800.00%-45M | 97.85%-55M | -1,289.00%-2.9B | 186.08%68M | -292.31%-408M | 89.36%-5M | -12,280.95%-2.56B |
Net proceeds payment for loan | 97.06%134M | 43.42%109M | 229.03%40M | -31.58%13M | -800.00%-28M | 207.94%68M | 246.15%76M | -875.00%-31M | 190.48%19M | -33.33%4M |
Net PPE purchase and sale | 10.62%-1.41B | 7.67%-337M | 0.99%-399M | 6.80%-370M | 26.47%-300M | -21.47%-1.57B | -5.80%-365M | -19.23%-403M | -22.53%-397M | -41.67%-408M |
Net business purchase and sale | 189.86%390M | 13,150.00%522M | 71.12%-132M | --0 | --0 | -108.98%-434M | -33.33%-4M | -109.34%-457M | --5M | 138.60%22M |
Net other investing changes | -192.77%-972M | -126.51%-487M | -255.26%-135M | -561.11%-238M | -160.47%-112M | -95.29%-332M | -56.93%-215M | -245.45%-38M | -125.00%-36M | -616.67%-43M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 59.37%-2.1B | 56.59%-191M | 41.96%-776M | -54.59%-640M | 83.41%-495M | -267.01%-5.17B | 28.57%-440M | -130.07%-1.34B | -1.47%-414M | -820.68%-2.98B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -78.09%-7.65B | -159.84%-3.25B | 117.07%439M | -430.80%-2.31B | -6,735.14%-2.53B | 61.80%-4.29B | 52.58%-1.25B | 53.38%-2.57B | 52.51%-435M | 98.30%-37M |
Net issuance payments of debt | 481.29%1.06B | -168.53%-768M | 152.52%833M | -565.10%-893M | 34.66%1.89B | 89.14%-278M | 43.70%-286M | 12.23%-1.59B | -12.33%192M | 402.81%1.4B |
Net common stock issuance | -220.89%-6.73B | -325.53%-2B | 110.88%62M | -660.00%-950M | -312.12%-3.84B | 70.95%-2.1B | 71.70%-470M | 83.24%-570M | 85.83%-125M | 26.90%-932M |
Cash dividends paid | -8.07%-1.57B | -7.26%-384M | -7.73%-390M | -8.29%-392M | -8.97%-401M | -4.77%-1.45B | -7.19%-358M | -6.16%-362M | -2.84%-362M | -3.08%-368M |
Net other financing charges | 12.37%-411M | 29.41%-96M | -22.22%-66M | 47.14%-74M | -25.90%-175M | -493.67%-469M | -2.26%-136M | -274.19%-54M | -241.41%-140M | -82.89%-139M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -78.09%-7.65B | -159.84%-3.25B | 117.07%439M | -430.80%-2.31B | -6,735.14%-2.53B | 61.80%-4.29B | 52.58%-1.25B | 53.38%-2.57B | 52.51%-435M | 98.30%-37M |
Net cash flow | ||||||||||
Beginning cash position | 39.51%8.34B | -15.94%7.18B | -22.61%7.46B | 26.97%10.14B | 39.51%8.34B | 7.71%5.98B | 20.08%8.55B | 95.73%9.64B | 57.89%7.99B | 7.71%5.98B |
Current changes in cash | -73.82%614M | 895.07%1.77B | 73.13%-291M | -263.36%-2.68B | -9.56%1.82B | 356.23%2.35B | 80.66%-223M | -148.96%-1.08B | 2,153.75%1.64B | 531.83%2.01B |
Effect of exchange rate changes | -225.00%-20M | -285.71%-26M | 357.14%18M | -175.00%-3M | -280.00%-9M | 118.60%16M | 16.67%14M | 61.11%-7M | 107.02%4M | 121.74%5M |
End cash position | 7.12%8.93B | 7.12%8.93B | -15.94%7.18B | -22.61%7.46B | 26.97%10.14B | 39.51%8.34B | 39.51%8.34B | 20.08%8.55B | 95.73%9.64B | 57.89%7.99B |
Free cash flow | -12.53%8.96B | 342.38%4.88B | -114.57%-353M | -105.01%-105M | -1.73%4.54B | 39.11%10.24B | -37.17%1.1B | -17.72%2.42B | 127.72%2.1B | 165.21%4.62B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |